Mobile Phones & Personal Device Exposure

A multicenter case-control study in Iran reported that self-reported prolonged mobile phone use was associated with higher odds of confirmed and suspected breast cancer status. The authors emphasize that the findings do not imply causation and note limitations including self-reported exposure and potential residual confounding. They call for larger prospective studies with objective exposure assessment.

RF Safe argues that marketing claims such as “blocks 99% of EMF” for anti-radiation phone cases are misleading because many “lab tests” are reportedly performed on shielding fabric alone rather than on a working phone. The piece frames a phone as a “dynamic radio” and suggests real-world performance may differ from simplified test setups. The extracted text also promotes RF Safe’s products and warranty, indicating a commercial/advocacy context.

RF Safe argues that Media Bias/Fact Check (MBFC) downgraded RF Safe partly by citing an FDA webpage stating typical RF exposure is not supported by current evidence as a health risk, but that the cited FDA page now redirects to a general “Cell Phones” landing page. The post claims other historically cited FDA consumer pages also redirect and that the strongest reassurance language is now mainly accessible via archives. It further cites Reuters reporting that FDA removed outdated webpages about cellphone safety alongside HHS launching a new study, and contends MBFC should update its rationale and links.

RF Safe criticizes Media Bias/Fact Check (MBFC) for rating it “medium credibility,” arguing MBFC relied on an FDA webpage that was later changed/redirected and on a Harvard T.H. Chan School commentary. The post claims the FDA removed categorical reassurance language about cell phone safety and frames this as undermining MBFC’s critique. It also asserts that non-thermal mechanisms and animal findings support RF Safe’s precautionary stance, while characterizing MBFC’s sources as “opinion” rather than data.

A rat study in Bioelectromagnetics examined GSM-modulated 3.5 GHz RF-EMF exposure (2 h/day for 30 days) and reported adverse changes in male reproductive hormones, oxidative stress markers, and testicular histology. The authors also tested Coenzyme Q10 (CoQ10) and found it partially ameliorated some RF-associated alterations. The paper notes that because the exposure used a GSM-modulated waveform, findings cannot be extrapolated to FR1 5G NR signals, and calls for further research under real-world conditions.

This RF Safe commentary argues that HHS, under Secretary Robert F. Kennedy Jr., was correct to remove FDA webpages that gave broad assurances that cell phone radiation is “not dangerous.” It claims blanket safety messaging is scientifically indefensible given animal toxicology findings (notably the U.S. National Toxicology Program studies), a WHO-commissioned systematic review of animal cancer studies (Mevissen et al., 2025), and references to federal court findings. The piece frames the change as a precautionary, science-based correction rather than an anti-science move.

This RF Safe commentary argues that Reuters-reported actions by HHS and FDA—launching an HHS study and removing older FDA webpages stating cellphones are “not dangerous”—should be understood as a risk-communication/scientific-integrity adjustment rather than a declaration of confirmed harm. It contends that categorical safety messaging is not justified given mixed evidence, citing the D.C. Circuit’s 2021 decision criticizing FCC reliance on conclusory FDA statements, along with selected human, animal, and mechanistic literature. The post calls for more uncertainty-aware, evidence-graded public messaging about RF exposure from phones.

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review (Mevissen et al., 2025) as motivation, emphasizing reported tissue-selective findings and non-monotonic dose patterns. The post proposes a mechanistic framework (“S4–Mito–Spin”) and calls for research to map boundary conditions across tissues and exposure parameters to inform standards beyond SAR/thermal assumptions.

This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard control) and signals a shift from definitive safety messaging toward renewed inquiry, while noting that details of any planned research have not been publicly disclosed. The piece also highlights Kennedy’s past public statements alleging harms from Wi‑Fi/5G and links the policy context to the 2021 D.C. Circuit remand of FCC RF policy.

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing prior “safety conclusion” language while HHS has announced a new study on electromagnetic radiation and health effects, framing these as a meaningful shift in federal public-facing posture. The piece further points to the Ramazzini Institute animal study as suggesting similar tumor signals at lower exposure levels, while acknowledging animal studies alone do not establish human causation.

RF Safe reports that HHS confirmed plans to launch a new study on cellphone radiation and that an HHS spokesperson said the FDA removed webpages with “old conclusions” while new research is undertaken to identify knowledge gaps, including for emerging technologies. The article frames the FDA webpage changes as a meaningful shift away from categorical reassurance, while noting Reuters’ reporting that some FDA and CDC pages still state there is no credible evidence of health problems from cellphone radiation. It also links the development to the 2021 D.C. Circuit decision in Environmental Health Trust v. FCC, arguing the ruling exposed weaknesses in the FCC’s reliance on other agencies’ statements.

RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), emphasizing research, monitoring, and public information rather than definitive safety conclusions. It also links the change to a reported HHS announcement of a new study and portrays the update as a shift toward greater transparency, while noting some safety language may remain on the page.

RF Safe recounts a timeline of FTC actions and consumer guidance targeting phone “radiation shield” stickers/patches that claimed large reductions in exposure, arguing these products can create a false sense of security. The post cites the FTC’s February 2002 enforcement actions and consumer alert, including references to Good Housekeeping Institute testing that reportedly found the products did not reduce exposure. RF Safe also claims it warned about such scams earlier (late 1990s), framing this as its own account rather than an FTC-attributed origin story.

RF Safe promotes its QuantaCase (also called TruthCase) as a leading “anti-radiation” phone case for 2026, emphasizing a directional shielding design intended to deflect RF energy away from the body. The article argues the product aligns with consumer-safety guidance such as keeping phones away from the body and using hands-free modes, and it claims RF Safe’s earlier advocacy influenced FTC/FCC warnings about ineffective or counterproductive shielding products. It cites comparisons, user reviews, and an “independent” 2017 TV review as support, but presents limited verifiable technical detail in the excerpt.

RF Safe argues that many “anti-radiation” phone cases market misleading “% blocked” claims based on lab material tests rather than whole-device, real-world performance. The article promotes RF Safe’s TruthCase/QuantaCase as a “physics-first” design that avoids advertising a single blocking percentage and emphasizes directional shielding and user education. It cites a 2017 CBS San Francisco/KPIX test as an example of how some flip-style shielding cases can reduce measured RF in certain orientations but may increase readings in other common-use configurations.

RF Safe argues that “no effect” findings in some RF exposure studies should be interpreted as meaningful negative controls rather than as evidence that RF has no biological effects. The post presents RF Safe’s “S4–Mito–Spin” framework, claiming certain skin cell types (fibroblasts and keratinocytes) are predicted to be relatively resistant to non-thermal RF effects, so null results in these cells can be consistent with the model. It cites in-vitro studies at 3.5 GHz (5G-modulated) reporting no changes in ROS measures, stress responses, or UV-B DNA repair kinetics under specified SAR conditions, and frames these nulls as boundary conditions rather than a general safety conclusion.

RF Safe presents itself as an RF exposure advocacy and education project promoting “RF exposure literacy,” safer-use habits, and updated safety frameworks beyond thermal-only assumptions. The post highlights RF Safe’s tools, including a SAR comparison database based on FCC SAR data, a public research viewer described as containing 4,000+ peer-reviewed studies, and its “TruthCase”/editorial standards. It argues that non-thermal biological interactions are reported in experimental literature and that compliance with current SAR limits does not necessarily reflect optimal real-world exposure outcomes.

RF Safe publishes a rebuttal to Media Bias Fact Check’s (MBFC) decision to rate the site “Medium Credibility,” addressing MBFC’s concerns about selective citation, one-sided interpretation, alarmist framing, and potential conflicts of interest tied to selling RF-safety products. The post argues RF Safe includes null/negative findings, avoids claiming RF “causes” specific diseases, and maintains editorial/transparency policies meant to separate evidence types and disclose commercial relationships. It also contends MBFC’s critique is partly a dispute over tone and wording (e.g., “primarily” funded by product sales) rather than demonstrated sourcing errors.

RF Safe publishes a correction request addressed to Media Bias Fact Check (MBFC) regarding MBFC’s credibility entry about RF Safe. The post argues that MBFC should revise or substantiate claims about RF Safe being “funded primarily” by product sales, adjust conflict-of-interest wording, and reconsider an assertion that RF Safe gives limited weight to null (no-effect) evidence. RF Safe proposes alternative language and links to its own transparency policy, product education pages, and a framework it says explicitly anticipates null results.

RF Safe publishes a commentary disputing Media Bias Fact Check’s (MBFC) labeling of RF Safe as “pseudoscience” with “mixed factual reporting” and “low credibility.” The post argues MBFC mischaracterized RF Safe’s content as overstating evidence about cell phones and health, claiming RF Safe generally uses cautious, study-referencing language (e.g., “associations,” “potential risks”) and avoids asserting direct human causation. It also points to RF Safe disclaimers that the site is educational and not medical advice, and highlights its research library linking to primary studies such as NTP and Ramazzini animal findings.

RF Safe argues that many “anti-radiation” phone cases use misleading marketing (e.g., fabric-swatch tests, vague “FCC tested” claims) and that some designs may cause phones to increase transmit power if they interfere with antennas. The article provides a checklist of red flags (magnets/metal plates, detachable shields, unclear orientation instructions) and emphasizes behavioral steps to reduce RF exposure. It promotes RF Safe’s QuantaCase as a “directional shielding” design intended to reduce exposure on the body-facing side while avoiding signal blockage that could prompt higher power output.

RF Safe argues that celebrity-branded mobile services (citing reported plans for “Beast Mobile” and the announced “Trump Mobile”) could normalize near-body, all-day phone use—especially among children—and therefore carry ethical responsibility for scaled RF exposure. The piece cites legal and scientific developments (including the 2021 Environmental Health Trust v. FCC decision, the U.S. NTP animal studies, and a WHO-commissioned systematic review) to claim the evidence base has “moved decisively” toward concern about long-term RF-EMF effects. It also promotes a proposed mechanistic framework ("S4–Mito–Spin") and suggests shifting indoor connectivity toward Li‑Fi (IEEE 802.11bb) as a harm-reduction approach.

This animal study tested whether short-term 28 GHz (5G-band) millimeter-wave exposure modifies doxorubicin-induced cardiotoxicity in male rats and whether vitamin C mitigates effects. Co-exposure to 28 GHz EMR was reported to worsen several indices of DOX-related cardiac injury (including CAT reduction, increased BAX expression, and QT prolongation), while vitamin C provided partial attenuation. The authors emphasize that results are limited to a short-duration preclinical model and that human relevance remains preliminary.

This magazine article discusses the rising incidence of thyroid cancer and raises the possibility of an association with increased smartphone use and related RF EMF exposure near the head and neck. It characterizes EMF exposure from personal electronics as a growing public health concern. The piece calls for more research, monitoring, and public awareness, and mentions precautionary measures.

This exposure assessment measured outdoor micro-environment RF-EMF levels in daily-life settings across urban and suburban locations in Japan using a portable device (50 MHz–6 GHz) with GPS. Reported exposure levels were higher in urban areas, with railway stations showing the highest levels among the environments measured. The authors emphasize the need for further comprehensive studies and frame prolonged RF-EMF exposure as an ongoing public health concern.

This animal experiment assessed GSM-modulated 3.5 GHz RF exposure in male Wistar rats and reported hormonal, oxidative, and histological changes consistent with testicular impairment. RF exposure was associated with lower testosterone, LH, and FSH, higher oxidative stress (increased MDA and TOS), and degenerative testicular histology. Coenzyme Q10 supplementation partially mitigated several reported changes. The authors caution against generalizing these results to FR1 5G NR signals and call for further research.

This rat study examined acute (1-week) and chronic (10-week) exposure to 2100 MHz radiofrequency radiation (3G UMTS-like) and assessed auditory mismatch negativity (MMN) alongside biochemical and histological brain measures. The abstract reports that acute exposure was associated with reduced MMN-related electrophysiological parameters and changes in GluR2 and GFAP with observed brain ultrastructural alterations. Chronic exposure showed opposite protein trends and enhanced MMN parameters versus chronic controls, and lipid peroxidation was not significantly different.